Pathology
Main Filters
Pathology
| IQ Products B.V. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| IQP-567D | 0 | - | ||
| IQP-567F | 0 | - | ||
| IQP-567P | 0 | - | ||
| IQP-567R | 0 | - | ||
| IQP-568C | 0 | - | ||
| IQP-568F | 0 | - | ||
| IQP-568P | 0 | - | ||
| IQP-568R | 0 | - | ||
| IQP-569R | 0 | - | ||
| IQP-570B | 0 | - | ||
| IQP-570F | 0 | - | ||
| IQP-570P | 0 | - | ||
| IQP-570R | 0 | - | ||
| IQP-574F | 0 | - | ||
| IQP-574P | 0 | - | ||
| Kreatech Biotechnology B.V. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 01Q006V495 | 0 | - | ||
| 11Q008V550 | 0 | - | ||
| 11Q009V495 | 0 | - | ||
| 12C002V495 | 0 | - | ||
| 12Q001V550 | 0 | - | ||
| 12Q002V550 | 0 | - | ||
| 12Q003V495 | 0 | - | ||
| 13Q005V495 | 0 | - | ||
| 13Q006V550 | 0 | - | ||
| 16P001V495 | 0 | - | ||
| 16P002V550 | 0 | - | ||
| 18Q005V495 | 0 | - | ||
| 18Q006V550 | 0 | - | ||
| 22Q004V550 | 0 | - | ||
| 22Q005V495 | 0 | - | ||
| LEICA BIOSYSTEMS MELBOURNE PTY LTD | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 21.2201 | 0 | - | ||
| 49.0051 | 0 | - | ||
| S21.1971 | 0 | - | ||
| Mechatronics USA LLC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| A0016912 | 0 | - | ||
| NanoEnTek, Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| FRBR 015 | 0 | - | ||
| SAKURA FINETEK U.S.A., INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1429 | 0 | - | ||
| 3980 | 0 | - | ||
| 3990 | 0 | - | ||
| 4010 | 0 | - | ||
| 4011 | 0 | - | ||
| 4012 | 0 | - | ||
| 4013 | 0 | - | ||
| 4014 | 0 | - | ||
| 4015 | 0 | - | ||
| 4016 | 0 | - | ||
| 4017 | 0 | - | ||
| 4038 | 0 | - | ||
| Tecan Austria GmbH | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 30087537 | 0 | - | ||
| 30087538 | 0 | - | ||
| VITO HEALTH PTY LTD | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1 | 0 | - | ||
18,175 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
BOND
LEICA BIOSYSTEMS MELBOURNE PTY LTD
BOND Mixing Station contains six cavities that are used to mix shortlife reagents that must be mixed just before use. The mixing of the reagents is determined by thesoftware, depending on reagent type.
0
-
BOND-MAX Processing Module
LEICA BIOSYSTEMS MELBOURNE PTY LTD
The BOND system automates clinical protocols for immunostaining of pathology specimens mounted on microscope slides. Microscope slides subsequently undergo interpretation by a qualified healthcare professional to aid diagnosis.
0
-
BOND-III processing module
LEICA BIOSYSTEMS MELBOURNE PTY LTD
The BOND system automates clinical protocols for immunostaining of pathology specimens mounted on microscope slides. Microscope slides subsequently undergo interpretation by a qualified healthcare professional to aid diagnosis.
0
-
Sapyen At-Home Male Fertility Analysis Kit
VITO HEALTH PTY LTD
Sapyen At-Home Male Fertility Analysis Kit - At-home male fertility diagnostic kit, which enables customers to collect semen samples from the comfort of their own home without having to rush out the door to drop their sample to the nearest testing centre. Our kit extends the shelf life of sperm, so customers can send their sample via normal postal services to accredited labs for semen analysis. After the analysis, customers receive a comprehensive report explaining the results on each of their parameters and providing recommendations that consider their health history.
0
-
FREND Blocking Reagent
NanoEnTek, Inc.
FREND™ Blocking Reagent is provided in 15 tubes, the blocking reagent is buffer based containing constituents of human origin as well as purified chemicals. Preservatives and stabilizers have been added to maintain product integrity. The Blocking Reagent is provided in a dried solid state.
0
-
CD64 R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody CD64 (clone 32.2) binds a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa. The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 FITC
IQ Products B.V.
The FITC conjugated monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 CyQ
IQ Products B.V.
The CyQ conjugated monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presence of human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD64 PURE
IQ Products B.V.
The purified monoclonal antibody CD64 (clone 22) binds to a CD64 epitope distinct from the ligand-binding site and from the clone 32.2 antibody to CD64 epitope. It shows especially high affinity binding to human mononuclear phagocytes and polymorphonuclear leukocytes exposed to IFN-y or G-CSF. Its binding is not blocked in the presenceof human IgG or immune complexes.CD64 reacts with the Fc gamma receptor 1 (FcyR1), a glycoprotein with a molecular weight of 72 kDa.The antigen is a high-affinity receptor for IgG and is able to bind human IgG1 and IgG3. The antigen is expressed on macrophages, monocytes, and interferon y (IFN-y) and Granulocyte Colony Stimulating Factor (G-CSF) stimulated neutrophils.
0
-
CD163 Biotin
IQ Products B.V.
The Biotin conjugated monoclonal antibody CD163 (clone MAC2-158) detects human CD163. It targets an epitope within the SRCR1 domain from the N-terminal region.
0
-
CD163 R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody CD163 (clone MAC2-158) detects human CD163. It targets an epitope within the SRCR1 domain from the N-terminal region.
0
-
CD163 FITC
IQ Products B.V.
The FITC conjugated monoclonal antibody CD163 (clone MAC2-158) detects human CD163. It targets an epitope within the SRCR1 domain from the N-terminal region.
0
-
CD163 PURE
IQ Products B.V.
The purified monoclonal antibody CD163 (clone MAC2-158) detects human CD163. It targets an epitope within the SRCR1 domain from the N-terminal region.
0
-
anti-HbS FITC
IQ Products B.V.
The FITC conjugated monoclonal antibody anti-Hemoglobin S (HbS) recognizes the B-chain of the human hemoglobin.
0
-
anti-HbS PURE
IQ Products B.V.
The purified monoclonal antibody anti-Hemoglobin S (HbS) recognizes the B-chain of the human hemoglobin.
0
-
Anti-HbF Dy-410
IQ Products B.V.
The Dy-410 conjugated monoclonal antibody anti-Hemoglobin F (HbF1) reacts with the y-chain of the human fetal hemoglobin molecule in its intact form.
0
-
Anti-HbF R-PE
IQ Products B.V.
The R-PE conjugated monoclonal antibody anti-Hemoglobin F (HbF1) reacts with the y-chain of the human fetal hemoglobin molecule in its intact form.
0
-
Anti-HbF FITC
IQ Products B.V.
The FITC conjugated monoclonal antibody anti-Hemoglobin F (HbF1) reacts with the y-chain of the human fetal hemoglobin molecule in its intact form.
0
-
Anti-HbF PURE
IQ Products B.V.
The purified monoclonal antibody anti-Hemoglobin F (HbF1) reacts with the y-chain of the human fetal hemoglobin molecule in its intact form.
